期刊文献+

造血干细胞移植后EB病毒感染的细胞免疫治疗 被引量:5

Cellular Immune Therapy for Epstein-Barr Virus Infection after Hematopoietic Stem Cell Transplantation——Review
下载PDF
导出
摘要 造血干细胞移植是治疗恶性血液病的有效措施,由于移植后免疫抑制剂的使用,机体免疫功能受到影响,病毒感染在造血干细胞移植后具有很高的发生率。EB病毒(Epstein-Barr virus,EBV)感染是移植后常见的病毒感染之一,其诱发的移植后淋巴细胞增殖性疾病虽然发生率低,但疾病进展快,死亡率高。T淋巴细胞在机体抗病毒免疫中发挥着重要作用,基于病毒特异性细胞毒性T淋巴细胞(cytotoxic T lymphocyte,CTL)的细胞免疫治疗显示了很好的安全性及有效性。本文回顾了近几年国内外细胞免疫疗法治疗EB病毒感染的最新进展,包括制备方法的改进、新分离方法的使用及第三方CTL的应用,并探讨EB病毒感染细胞免疫治疗的临床应用前景及存在的问题。 Hematopoietic stem cell transplantation is an ettective method for treatment of hematologic malignancies.Due to the use of immunosuppressive agents and a long time of immune restoration after transplantation,the incidence of virus infection is high.Epstein-Barr virus(EBV) infection is a common viral infection after transplantation.In spite of the low incidence of post transplantation lymphoproliferative disorder(PTLD) caused by EBV,this disease is characterized by rapid progression and high mortality.T lymphocytes play an important role in anti-viral immunity,and the cellular immune therapy based on virus-specific cytotoxic T lymphocyte(CTL) is safe and efficient.This review presents the domestic and foreign advances in cellular immune treatment against EBV infection and explores the clinical application prospects as well as problems.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2015年第6期1763-1768,共6页 Journal of Experimental Hematology
基金 医院创新基金资助(201385)
关键词 EB病毒 造血干细胞移植 移植后淋巴细胞增殖性疾病 细胞免疫治疗 Epstein-Barr virus hematopoietic stem cell transplantation post transplantation lymphoproliferative disorder cellular immune therapy
  • 相关文献

参考文献35

  • 1Ann M. Leen,Helen E. Heslop,Malcolm K. Brenner.??Antiviral T‐cell therapy(J)Immunol Rev . 2014 (1)
  • 2Xin-Chao Wang,Hua Pang,Xun Xu,Anita Schmitt,Mathias Freund,Michael Schmitt,Bao-An Chen.??Streptamer versus tetramer-based selection of functional cytomegalovirus-specific T cells(J)Journal of the Formosan Medical Association . 2013 (6)
  • 3Michael Uhlin,Jens Gertow,Mehmet Uzunel,Mantas Okas,Sofia Berglund,Emma Watz,Mats Brune,Per Ljungman,Mark Maeurer,Jonas Mattsson.??Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease(J)Clinical Infectious Diseases . 2012 (8)
  • 4Michael Uhlin,Mantas Okas,Jens Gertow,Mehmet Uzunel,Torkel B. Brismar,Jonas Mattsson.??A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation(J)Cancer Immunology, Immunotherapy . 2010 (3)
  • 5Marcie Tomblyn,Tom Chiller,Hermann Einsele,Ronald Gress,Kent Sepkowitz,Jan Storek,John R. Wingard,Jo-Anne H. Young,Michael A. Boeckh.Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective[J].Biology of Blood and Marrow Transplantation.2009(10)
  • 6Lin R,Liu Q.Diagnosis and treatment of viral diseases in recipients ofallogeneic hematopoietic stem cell transplantation. J Hematol Oncol . 2013
  • 7HE Heslop,KS Slobod,MA Pule,GA Hale,A Rousseau,CA Smith,CM Bollard,H Liu,MF Wu,RJ Rochester,PJ Amrolia,JL Hurwitz,MK Brenner,CM Rooney.Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood . 2010
  • 8Doubrovina Ekaterina,Oflaz-Sozmen Banu,Prockop Susan E,Kernan Nancy A,Abramson Sara,Teruya-Feldstein Julie,Hedvat Cyrus,Chou Joanne F,Heller Glenn,Barker Juliet N,Boulad Farid,Castro-Malaspina Hugo,George Diane,Jakubowski Ann,Koehne Guenther.Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood . 2011
  • 9Catherine M. Bollard,Cliona M. Rooney,Helen E. Heslop.T-cell therapy in the treatment of post-transplant lymphoproliferative disease. NATURE REVIEWS CLINICAL ONCOLOGY . 2012
  • 10Pagliara Daria,Savoldo Barbara.Cytotoxic T lymphocytes for the treatment of viral infections and posttransplant lymphoproliferative disorders in transplant recipients. Current opinion in infectious diseases . 2012

二级参考文献21

  • 1陈育红,黄晓军,陈欢,许兰平,刘代红,江倩,张耀臣,韩伟,高志勇,王景枝,刘开彦,吴彤,陆道培.非血缘关系异基因造血干细胞移植66例分析[J].中华血液学杂志,2005,26(11):656-660. 被引量:19
  • 2Micallef IN,Chhanabhai M,Gascoyne RD,et al.Lymphoproliferative disorders following allogeneic bone marrow transplantation:the Vancouver experience.Bone Marrow Transplant,1998,22:981-987.
  • 3Gottschalk S,Rooney CM,Heslop HE.Post-transplant lymphoproliferative disorders.Annu Rev Med,2005,56:29-44.
  • 4Heslop HE.How I treat EBV lymphoproliferation.Blood,2009,114:4002-4008.
  • 5Burnsa DM,Crawfordb DH.Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.Blood Rev,2004,18:193-209.
  • 6Choquet S,Leblond V,Herbrecht R,et al.Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders:results of a prospective multicenter phase 2 study.Blood,2006,107:3053-3057.
  • 7Rooney CM,Smith CA,Ng CY,et al.Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.Blood,1998,92:1549-1555.
  • 8Weinstock DM,Ambrossi GG,Brennan C,et al.Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplantation lymphoproliferative disorder after hematopoietic stem cell transplant:an approach in development.Bone Marrow Transplant,2006,37:539-546.
  • 9Heslop HE,Ng CY,Li C,et al.Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.Nat Med,1996,2:551-555.
  • 10Steven NM,Leese AM,Annels NE,et al.Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.J Exp Med,1996,184:1801-1813.

共引文献15

同被引文献47

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部